About Novalithera Sciences
We are an AI-driven biotherapeutic company at the intersection of machine learning and molecular biology, dedicated to transforming how novel treatments are discovered and developed.
We are an AI-driven biotherapeutic company at the intersection of machine learning and molecular biology, dedicated to transforming how novel treatments are discovered and developed.
Novalithera Sciences brings together computational scientists, bioinformaticians, and drug discovery experts who collaborate at the intersection of machine learning and molecular biology. Our multidisciplinary team is united by a shared mission: to leverage the power of artificial intelligence to accelerate the discovery and development of next-generation biotherapeutics.
We operate proprietary training and inference clusters that process vast biological datasets — from genomic sequences to protein structures — enabling predictive modeling at enterprise scale. Every engagement is custom-tailored: we work closely with each enterprise partner to design computational pipelines that address their specific research objectives and therapeutic programs.
With offices across multiple continents, we serve a growing network of pharmaceutical companies, biotechnology firms, healthcare organizations, and academic research institutes. Our global presence ensures close collaboration with partners while maintaining rigorous data security and operational standards.
"To democratize access to advanced AI-driven drug discovery — empowering every research organization to explore the vast therapeutic potential encoded in biological data, and to bring life-changing treatments to patients faster than ever before."
Our culture and decision-making are guided by core principles that reflect our commitment to science, our partners, and the patients we ultimately serve.
Every prediction is validated. We hold our AI models to the same standards of evidence as experimental biology.
We embed ourselves in our partners' research programs, treating their goals as our own and adapting to their evolving needs.
We continuously push the boundaries of what AI can achieve in biology, investing heavily in research and infrastructure.
We safeguard partner data with enterprise-grade security and maintain the highest standards of data governance and privacy.
Novalithera Sciences was founded by a team of scientists and engineers with deep expertise across computational biology, machine learning, and drug development.
Leads the scientific vision and oversees the development of our AI models for target discovery and protein design. Brings extensive experience in computational biology and machine learning research.
Architects and manages our proprietary training and inference infrastructure. Oversees the engineering teams building scalable, secure, and performant computational platforms.
Drives operational excellence and partner relationships, ensuring that every enterprise engagement delivers measurable value. Manages global operations across multiple continents.
Key milestones in building Novalithera Sciences into a leading AI-driven biotherapeutic discovery company.
Novalithera Sciences was established by a multidisciplinary team of computational scientists and drug discovery experts united by the vision of AI-accelerated biotherapeutic discovery.
Built and deployed dedicated training and inference clusters optimized for large-scale biological AI workloads, establishing the computational foundation for our platform.
Expanded global footprint with offices across North America, Europe, Middle East, and Latin America to serve our growing network of enterprise partners worldwide.
Continuing to grow our portfolio of enterprise collaborations across the pharmaceutical, biotechnology, and healthcare sectors — delivering tailored AI solutions that accelerate therapeutic programs.